STEPHEN J HOFFMAN
CIK 1190418 · Chief Executive Officer · last filed 2025-10-24
STEPHEN J HOFFMAN is a Chief Executive Officer who has filed 41 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for TLPH, was dated Oct 24, 2025. Across all open-market trades the lifetime net is +$9.4M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $7.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$7.7K
7
41
$9.40M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TLPH | Director | 8,859 | $0.87 | $7.7K | $0 | 2 | 2025-10-24 |
| TALPHERA, INC. (ACRX) Delisted | Director | 2,874,351 | $0.86 | $2.47M | $0 | 8 | 2023-12-13 |
| Dicerna Pharmaceuticals Inc (DRNA) Delisted | Director | 312,000 | $38.22 | $11.92M | $3.00M | 9 | 2021-12-29 |
| Whitehawk Therapeutics, Inc. (ARPO) Delisted | Chief Executive Officer | 1,967 | $33.00 | $64.9K | $64.1K | 3 | 2019-05-16 |
| GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | Director | 1,992,415 | $0.00 | $1.2K | $8.79M | 4 | 2016-06-07 |
| ALLOS THERAPEUTICS INC (ALTH) Delisted | Director | 0 | — | — | -$2.45M | 12 | 2012-09-05 |
| Sirtris Pharmaceuticals, Inc. (SIRT) Delisted | Director | 1,376,190 | — | — | $0 | 1 | 2007-05-31 |
Recent Filings
41 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-10-24 | TLPH | Grant (A) | +4,267 | $0 | EDGAR |
| 2024-06-24 | TLPH | Grant (A) | +2,174 | $0 | EDGAR |
| 2023-12-13 | TALPHERA, INC. (ACRX) Delisted | Grant (A) | +581 | $0 | EDGAR |
| 2022-07-15 | TALPHERA, INC. (ACRX) Delisted | Grant (A) | +15,500 | $0 | EDGAR |
| 2021-12-29 | Dicerna Pharmaceuticals Inc (DRNA) Delisted | Mixed | −16,157 | -$618.0K | EDGAR |
| 2021-06-17 | TALPHERA, INC. (ACRX) Delisted | Grant (A) | +10,000 | $0 | EDGAR |
| 2021-06-07 | Dicerna Pharmaceuticals Inc (DRNA) Delisted | Mixed | +3,333 | $0 | EDGAR |
| 2020-06-16 | Dicerna Pharmaceuticals Inc (DRNA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-16 | TALPHERA, INC. (ACRX) Delisted | Grant (A) | +7,500 | $0 | EDGAR |
| 2019-06-25 | TALPHERA, INC. (ACRX) Delisted | Grant (A) | +3,750 | $0 | EDGAR |